Before a child begins any form of hormone-based treatment, parents participate in a process known as pediatric hormone therapy informed consent. While many families think informed consent is simply signing paperwork, it is actually a detailed educational discussion designed to help parents fully understand their child's diagnosis, treatment options, expected outcomes, and responsibilities throughout care.
Whether a child is being evaluated for growth hormone deficiency, low IGF-1, pituitary disorders, or another growth-related condition, informed consent is one of the most important steps in the treatment process.
The goal is not simply obtaining permission to begin therapy. The goal is helping families make confident, informed decisions based on a clear understanding of benefits, risks, alternatives, and long-term expectations.
What Is Pediatric Hormone Therapy Informed Consent?
Informed consent is a structured conversation between healthcare providers and parents before treatment begins.
During this process, families receive information about:
- The child's diagnosis
- Why treatment is being considered
- Available alternatives
- Potential benefits
- Possible side effects
- Monitoring requirements
- Long-term expectations
Parents have the opportunity to ask questions, discuss concerns, and understand every aspect of the proposed treatment plan.
This shared decision-making approach helps families feel comfortable and confident moving forward.
Why Informed Consent Is So Important
Hormone therapy often affects growth and development over several years.
Because treatment can be a significant commitment, parents deserve a complete understanding of what to expect.
Informed consent helps families understand:
- Why treatment is recommended
- Whether treatment is medically necessary
- What outcomes are realistic
- How long therapy may continue
- What monitoring is required
This process strengthens trust between families and providers while helping ensure treatment decisions align with family goals.
Understanding the Diagnosis Comes First
Before discussing treatment, providers first explain the child's diagnosis.
Many families begin this process through a child height specialist consultation or a pediatric growth evaluation appointment.
The evaluation helps determine whether a child has:
- growth hormone deficiency
- idiopathic short stature
- constitutional growth delay
- delayed puberty
- low IGF-1
- pituitary disorders
- poor growth velocity
Understanding the cause of slow growth is essential because treatment recommendations depend on the diagnosis.
Reviewing Growth Patterns and Testing Results
During informed consent discussions, providers review the information gathered during the evaluation process.
This often includes:
Growth Chart Analysis
Doctors explain growth trends and whether a child is following an expected pattern.
Growth Velocity Assessment
Children with poor growth velocity may require additional evaluation and monitoring.
Bone Age Assessment
A bone age assessment helps estimate remaining growth potential and future height expectations.
Children with delayed bone age often have more growth remaining than their chronological age suggests.
Hormone Testing
Testing may evaluate:
- Growth hormone production
- IGF-1 levels
- Thyroid function
- Other endocrine markers
These results help determine whether treatment may be beneficial.
Discussion of Available Treatment Options
One of the most important parts of informed consent involves reviewing all reasonable treatment approaches.
Parents should understand that treatment is not always necessary.
Possible options may include:
Observation and Monitoring
Some children with constitutional growth delay simply need ongoing monitoring and reassurance.
Growth Hormone Therapy
Children meeting established growth hormone therapy medical necessity criteria may be candidates for treatment.
Families often learn more about HGH for children to grow taller during these discussions.
Growth Hormone Stimulation Therapy
Some children may be evaluated for Sermorelin for children or other growth-hormone-stimulating therapies.
Additional Endocrine Treatments
Certain diagnoses require individualized treatment plans based on the underlying condition.
Parents should understand the benefits and limitations of each option before making decisions.
Understanding Expected Benefits
One of the most common questions parents ask is:
While no doctor can guarantee an exact adult height, providers explain realistic expectations based on:
- Current growth pattern
- Bone age
- Family height history
- Diagnosis
- Remaining growth potential
Potential benefits may include:
- Improved growth velocity
- Better growth curve progression
- Increased adult height potential
- Improved growth hormone signaling
Importantly, treatment aims to support normal growth—not create unrealistic height outcomes.
Discussing Risks and Side Effects
Parents also receive information about possible side effects.
Most children tolerate treatment well, but informed consent includes discussing potential risks.
Topics often include:
Common Temporary Symptoms
- Mild injection site discomfort
- Headaches
- Fluid retention
Rare Complications
Providers discuss uncommon but important concerns that require monitoring.
Situations Requiring Follow-Up
Families learn what symptoms should be reported promptly.
Parents frequently ask questions related to can kids overdose on growth hormone and can HGH stunt growth if misused.
These discussions help explain why proper dosing and ongoing monitoring are so important.
Understanding Monitoring Requirements
Treatment success depends heavily on consistent follow-up.
During informed consent, families learn about ongoing monitoring requirements.
These often include:
Growth Tracking
Height and weight measurements help evaluate treatment response.
Laboratory Testing
Children with low IGF-1 or other hormone abnormalities may require periodic testing.
Bone Age Assessment
Periodic bone age assessment studies help monitor skeletal maturity and growth potential.
Dose Adjustments
Medication doses often change as children grow.
Monitoring helps ensure treatment remains both safe and effective.
The Parent's Role During Treatment
Parents are active participants in their child's care.
Successful treatment depends on partnership between families and providers.
Responsibilities often include:
Administering Medication Correctly
Following prescribed instructions helps maintain treatment effectiveness.
Attending Follow-Up Visits
Regular appointments allow specialists to monitor progress.
Reporting Symptoms
Parents should communicate concerns promptly.
Supporting Healthy Growth Habits
Good sleep, nutrition, and overall health remain important even when medical treatment is used.
Questions Parents Should Ask During Informed Consent
Families should feel comfortable asking questions such as:
- Why is treatment being recommended?
- What are the alternatives?
- How long might therapy continue?
- What are the expected benefits?
- What side effects should we watch for?
- How often will monitoring occur?
- What happens if treatment is stopped early?
Many parents also ask about the safe age to start human growth hormone therapy and whether their child truly meets growth hormone therapy medical necessity criteria.
These are important discussions and should always be addressed before treatment begins.
Frequently Asked Questions
Is informed consent required before hormone therapy?
Yes. Informed consent is a standard part of pediatric hormone treatment.
Does signing consent mean treatment must begin?
No. Families may choose to proceed, delay treatment, or seek additional information.
Why is bone age discussed during consent?
A bone age assessment helps estimate remaining growth potential and influences treatment recommendations.
Can parents change their minds later?
Yes. Treatment decisions remain voluntary and can be revisited as circumstances change.
Is informed consent only for growth hormone therapy?
No. It applies to many pediatric hormone-based treatments.
The Bottom Line
Pediatric hormone therapy informed consent is far more than a signature on a form.
It is an educational process that helps families understand diagnoses such as growth hormone deficiency, idiopathic short stature, constitutional growth delay, delayed puberty, low IGF-1, pituitary disorders, and poor growth velocity before making treatment decisions.
Through discussions about treatment options, benefits, risks, monitoring, and expectations, parents gain the information needed to confidently participate in their child's care.
Whether a family is considering HGH for children to grow taller, Sermorelin for children, or another treatment approach, informed consent helps ensure decisions are thoughtful, collaborative, and focused on helping children reach their natural growth potential safely.
Medically Reviewed By
Dr. Devin Stone, ND
Dr. Devin Stone is a Doctor of Naturopathic Medicine and founder of HGHforChildren.com. His clinical focus includes pediatric growth optimization, growth hormone deficiency, delayed bone age assessment, constitutional growth delay, IGF-1 evaluation, and evidence-informed therapies designed to help children maximize healthy growth potential.
References
- Pediatric Endocrine Society. Patient Education Resources.
- Growth Hormone Research Society Consensus Guidelines.
- Endocrine Society Clinical Practice Guidelines.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Hormone Research in Paediatrics.
- American Academy of Pediatrics. Shared Decision Making in Pediatric Care.
- National Institutes of Health (NIH). Informed Consent in Pediatric Medicine.
- Grimberg A, et al. Guidelines for Growth Hormone and IGF-1 Treatment in Children and Adolescents.
Dr. Devin Stone
Contact Me
